CONFIRM: In this trial involving adults w/ cirrhosis and HRS-1, terlipressin was more effective than placebo in improving renal function but was associated with serious adverse events, including respiratory failure (ca. 2021) #Hepatorenal#Nephpearls nejm.org/doi/full/10.10β¦